Knowing the mutagenic and carcinogenic properties of chemicals is very important for their hazard (and risk) assessment. One of the crucial events that trigger genotoxic and sometimes carcinogenic effects is the forming of adducts between chemical compounds and nucleic acids and histones. This review takes a look at the mechanisms related to specific functional groups (structural alerts or toxicophores) that may trigger genotoxic or epigenetic effects in the cells. We present up-to-date information about defined structural alerts with their mechanisms and the software based on this knowledge (QSAR models and classification schemes).
Carcinogenicity is an important toxicity endpoint in assessing chemical risk and hazards. The human population is exposed to various chemical agents that may promote one of the three stages of cancer development (initiation, promotion, progression) (1) . Usually, the information about carcinogenic chemicals is gathered from animal or epidemiological studies (2) . According to the mechanism of action carcinogens can be divided into two major groups: a) genotoxic carcinogens, which directly interact with and damage DNA by changing its structure and b) epigenetic carcinogens, which do not directly damage DNA (through covalent bonds) but affect its expression or make the cell more sensitive to other agents. Epigenetic carcinogens act in a wide range of mechanisms, while genotoxic carcinogens have a quite similar mode of action. These compounds are usually highly reactive electrophilic molecules that interact with the nucleophilic site in DNA. They can be electrophilic per se or metabolised to reactive electrophilic intermediates by several cellular processes (3, 4) .
In the following sections we give an overview of some known mechanisms of carcinogenic action and of the software used to predict the mutagenicity and carcinogenicity of chemical compounds based on their structure. This software is a valuable tool in identifying and regulating potentially toxic chemicals.
With the efforts made to minimise animal testing (such as the EU ban to test animals for chemicals used in cosmetics industry), researchers have been looking for new, alternative methods to evaluate the toxic properties of molecules for specific endpoints such as carcinogenicity, mutagenicity, reproductive toxicity, developmental toxicity, skin sensitivity, and hepatotoxicity (2) .
The review is intended to assist everyone involved in chemical regulation who intend to use in silico models for hazard communication, regulatory compliance, and sustainable lifecycle management.
CARCINOGENESIS
Carcinogenesis is the result of a number of complex, sequential processes within cells and tissues triggered by a variety of molecular and cellular changes. If induced by chemical compounds, carcinogenesis has three stages: initiation, promotion, and progression ( Figure 1 ).
Carcinogenesis begins with a mutation, a stable, heritable change of a genetic material that has escaped DNA repair mechanisms during cell proliferation. In this initiation stage, mutations accumulate because they promote uncontrolled expression of proto-oncogenes, which control the cell cycle, including apoptosis and/or inactivation of tumour-suppressor genes (such as p53), which in turn encode enzymes for DNA damage repair. Initiation is a rapid, irreversible process in a number of mutational events triggered by chemical or physical agents (known as initiating agents or genotoxic agents).
The second stage is promotion. Under the influence of other endogenous or exogenous chemical compounds (growth stimuli) the initiated cells are subject to clonal growth, which promotes the tumour. This is why these exogenous and endogenous compounds are called tumour promoters. They are not mutagenic by themselves but trigger other mechanisms, such as changes in gene expression that are continued in all subsequent daughter cells. Cell proliferation rate increases and apoptotic cell death rate decreases. Promotion is a reversible process and only works in initiated cells. Well known promoters are phenobarbital, benzene, asbestos, and arsenic.
The last stage of carcinogenesis is progression, which involves additional genotoxic events (chromosomal aberrations and translocations). Progression is an irreversible process leading to the formation of neoplasms, benign and malignant alike (5-7).
Chemical carcinogens
Many genetic changes can occur spontaneously due to the presence of rare tautomers in nucleotide bases (keto/ enol form) and errors associated with the malfunctioning of DNA polymerases and oxidation of DNA induced by reactive oxygen species (ROS) because of respiratory chain and oxidative enzyme reactions (7) . However, more and more studies claim that the large increase in cancer incidence is associated with exposure to chemical carcinogens or with factors such as age, diet, hormonal balance, or environment (8) . About 80% of tumours in humans are triggered by exogenous chemical agents and are not necessarily associated with direct exposure to them but may also arise from normal metabolism, oxidative stress, or chronic inflammation. Chemical genotoxic carcinogens are divided into two main groups: direct-acting carcinogens and indirect-acting carcinogens. Direct-acting carcinogens cause cancer without metabolic activation or chemical modification (activation-independent), as they damage DNA from within. These chemicals are also known as parent compounds or ultimate carcinogens (9) . The most common are epoxides, imines, and alkyl and sulphate esters. Indirect-acting carcinogens become carcinogenic after metabolic activation. Typical indirect carcinogens are polycyclic aromatic hydrocarbons (PAHs, benzo[a]pyrene in particular), nitrosamines, nitrosoureas, and aromatic amines (10) (11) (12) .
Photogenotoxicity
One of the ways for chemical compounds to become genotoxic intermediates is through light activation (phototoxicity/photogenotoxicity). These compounds absorb light (UV, visible, and IR) and convert to another form (photomodification), degrade under the influence of light (photodegradation) (13) , or reach an excited state (photoexcitation). Some compounds such as psoralens and phenothiazines affect DNA directly through photoexcitation, some such as porphyrins and riboflavins excite the surrounding molecules (such as chromophores), and some (such as furocumarin hydroperoxides and peroxy esters) react with DNA via ROS (14) . Whichever the photogenotoxic mechanism, the compound must be excited close to the target (DNA) (13, 14) .
The most common changes affecting DNA are pyrimidine dimers, covalent adducts, base modifications generated by oxidation, single-strand breaks, and base loss. Under the influence of light, polycyclic aromatic hydrocarbons (PAHs) tend to form adducts that covalently bind to DNA or cause DNA strand breaks (13) . In these cases DNA repair mechanisms often fail, which can lead to photomutagenesis or even the initiation of photocarcinogenesis. Photogenotoxicity can be experimentally studied with different techniques such as HPLC coupled with tandem mass spectrophotometry (HPLC/MS-MS) or HPLC coupled with an electrochemical detector (HPLC/ECD) combined with the in vitro Comet assay or similar in vitro methods (15) .
Electrophiles as carcinogens
In their ultimate form, direct or indirect-acting chemical carcinogens (after metabolic activation) work as reactive electrophiles (11) . These compounds form covalent adducts with most of the cellular informational macromolecules (nucleophiles) such as DNA, RNA, or proteins. Nucleophiles contain nucleophilic sites that typically include electronrich (unpaired electrons) heteroatoms such as S (side chain of cysteine residues -thiol groups, S-atoms of methionine), O (alcohol group of the phenolic amino acid of tyrosine, 
Electrophilic chemical reaction mechanisms forming adducts with DNA
The understanding of the mechanisms of action through which electrophiles react with biological nucleophiles is based on the classical chemical reactions: conjugation, substitution, and addition, in which the electron-rich component interacts with the electron-deficient one (29) . We know of about fifty mechanisms of covalent binding, but only six can lead to cancer: S N , S N 2, acylation, Schiff base formation, Michael addition, and S N Ar (Figure 3 ). These mechanisms enable us to classify different electrophiles into appropriate mechanistic domain (Table  1 ) (30) . S N 1 is a first-order, two-stage nucleophilic substitution. In the first stage, the leaving group is branched off, and in the second stage, the resulting carbenium ion reacts with a nucleophile. S N 2 is a second-order nucleophilic substitution where the leaving group disconnects and attacks a nucleophile in a single step (31) . Acylation is a reaction where reactive tetrahedral intermediate is formed with a nucleophile, and the leaving group is released. Schiff base formation is a mechanism where electrophilic carbon atoms of aldehydes or ketones are attacked by amines and the C=O double bond is replaced by the C=N double bond (32) . Michael addition is a two-step nucleophilic addition, where nucleophile attacks a double bond and forms two new bonds. S N Ar is electrophilic aromatic substitution in which nucleophile attacks the leaving group and the aromatic structure stays unchanged (33, 34) .
Consequences of endogenous DNA adduct formation
DNA adducts may trigger different structural changes in genetic material (1, 3, 12) . Different chemicals react with different DNA bases on different DNA positions (4). The most common types of damage caused by DNA adducts are base oxidation, ethenobases, alkylation (usually methylation), and base hydrolysis (deamination or depurination). In deamination ammonia is released, and cytosine (adenine) is transformed into uracil (hypoxanthine), which causes the binding of adenine (cytosine) instead of guanine (thymine) when DNA is replicated. Depurination is the cleaving of the N-glycoside bond between the purine base and deoxyribose in DNA, leading to the formation of an apurinic site and structural change. Depurination of bases on a single-stranded DNA during replication can lead to mutation, because an incorrect base is added to the apurinic site (35) . This can lead to transversion or transition (36) . Electrophilic PAH metabolites are well-known examples of adducts that promote depurination. They are also capable of forming bulky DNA adducts. These PAH-DNA adducts can trigger nucleotide excision repair or affect important regulatory genes such as Ras and p53 (37, 38) . Bulky adducts can form a stable intercalation between the bases. Intercalators are planar molecules that intercalate between the base pairs in the double-stranded DNA. Intercalation changes the shape of the double helix and can cause serine, and threonine residues), and N (primary aminogroups of lysine or arginine, secondary amino-group of histidine) (16 (17, 18) . The most common reaction between electrophiles and nucleophiles is alkylation, especially of purine at the N 7 site of guanine. Alkylation may also occur at the O 6 site of guanine and other bases, but more slowly. The O 6 site is important for mutagenicity. The newly formed ether covalent bond is known to change the electronic distribution around the base, which leads to deprotonation at site N 1 . This changes the pattern of hydrogen bonds and causes misconnections between the bases (16, 19) . The targets of alkylation are not only nitrogen bases but also phosphodiester bonds (phosphate alkylation).
Each carcinogenic electrophile has a specific activation target, specific metabolism, and specific binding site on the nucleophile. Strong electrophiles are small, poorly polarised molecules, and their electron deficiency shows as positive electron charge. Soft electrophiles are usually large, highly polarised molecules, and their electron deficiency spreads all over the molecule (20, 21) . Strong (hard reactive) electrophiles include nitroso compounds, epoxides, α,β- 
Structural alerts for genotoxicity
In 1985, John Ashby introduced structural alerts as a way to predict genotoxicity ( Figure 2) (1). Benigni and Bossa (24) summarised structural alerts as follows: "The Structural Alerts are molecular substructures or reactive groups that are related to the carcinogenic and mutagenic properties of the chemicals, and represent a sort of 'codification' of a long series of studies aimed at highlighting the mechanisms of action of the mutagenic and carcinogenic chemicals". Structural alerts are very helpful not only in the classification of potential carcinogens, but are also important in understanding the mechanisms of genotoxicity (24) (25) (26) (27) (28) . 
Epigenetic mechanisms of carcinogenic molecules
Exposure to some chemical carcinogens may cause cancer without changes in the nucleotide sequences. Epigenetic factors are common in cells that are constantly under stress. Such chemicals do not form DNA adducts nor do they alter DNA but affect the expression of certain genes (28) . All epigenetic factors (physical, chemical, and biological) mainly operate in two ways: either via methylation or via post-translational modifications of histones (acetylation). DNA methylation occurs at the promoter region, which contains CpG islands (cytosine and guanine nucleotides linked with a phosphodiester bond) (46) and results in the conversion of cytosine to 5-methylcytosine, which has a much higher mutagenic potential. There are two mechanisms of methylation: hypermethylation and hypomethylation. Hypermethylation usually occurs at CpG islands and may affect genes involved in the cell cycle, DNA repair mechanisms, intercellular interactions, and apoptosis. Hypermethylation may also increase deamination of 5-methylcytosine to thymine, leading to C to T conversion. In contrast, hypomethylation at CpG sites may lead to the overexpression of oncogenes, chromosome instability, and metastases (47) .
Acetylation of histones is regulated by histone acetyl transferases (HATs), which play an important role in chromatin transformation and in the regulation of gene transcription (48) . Acetylation of lysine residues neutralises histones in the nucleosome and thus reduces their affinity to negatively charged DNA. Reduced affinity leads to the decondensation of DNA and eventually to transcription (49) . Histone acetylation does not affect histone affinity to DNA alone but also affects the interaction between histones and histone interaction with other regulatory proteins. In other words, histone acetylation may affect processes such as replication, formation of nucleosomes, and chromatin packaging (50) .
Cell exposure to oxidative stress and DNA damage
When we are talking about chemical carcinogenesis we cannot skip oxidative stress caused by reactive oxygen/ nitrogen species (ROS/RNS) (46 . These compounds can be generated by inflammation, radiation, interruption of mitochondrial oxidative phosphorylation, or xenobiotic metabolism, but most of them are generated by redox cycling induced by chemical carcinogens that contain structural alerts, such as halogenated compounds, aromatic hydrocarbons, aromatic N-oxides, quinones, aromatic nitro compounds, conjugated imines, heterocyclic amines, and pyridyl compounds (5, 30) . Oxidative stress arises when the redox balance is disrupted and the number of ROS/RNS exceeds the number of natural cell defence molecules (antioxidants), which leads to DNA, protein, and lipid damage (51) . Directly acting oxidative stress can cause structural DNA changes such as base pair substitution, deletion, insertion, base oxidation, guanine-to-cytosine or thymine-to-adenine transversion, double-or single strand-breaks, deamination of guanine and adenine, nitration of guanine, or modification of purine/ pyrimidine nucleosides (30) . Indirectly acting oxidative stress can change the membrane, cytoplasmic, and nuclear signal transduction pathways, modulate genes that increase cell proliferation or differentiation, and inhibit programmed cell death (apoptosis). Not only can ROS generate mutations but can also interfere with DNA repair (4).
The role or endocrine disruptors in carcinogenicity
In recent years the role of endocrine disruptors in carcinogenesis has received a lot of attention. Endocrine disrupting chemicals (EDC) can interfere with and affect the endocrine system, which can lead to hormone-related cancers (breast, testicular, prostate, or leukaemia). The main mechanism of EDC action is that they bind to the active sites of oestrogen, androgen, and thyroid receptors (52) . They can trigger the same response as natural hormones, agonistic or antagonistic alike. Ligand-receptor interactions most often result in changes in the transcription genes (53) , which, in turn, changes cell activities such as regulation/ stimulation of cell proliferation, regulation of gene expression, gene signalling, and hormone metabolism, biosynthesis, bioactivation, and degradation. Changes in hormonal levels affect DNA methylation, histone modifications, or apoptosis (54) . EDCs show some structural similarity to non-genotoxic compounds such as phenolic compounds, PAHs, isoflavonoids, stilbenes, and compounds with steroid structure (54) (55) (56) .
Other factors determining the carcinogenic potential of chemical compounds
Carcinogenicity and mutagenicity are not related only to structural alerts. Certain compounds may contain all of the structural alerts, but are not metabolically active inside the cell. Among the physiochemical factors that may hinder the functioning of these toxic molecules are: i) molecular weight and the size of chemicals: the higher the molecular weight of compounds, the lesser the chance they will be absorbed in significant amounts; ii) state of matter: affects the ability of a compound to reach the critical point; iii) solubility: highly hydrophilic compounds are poorly absorbed by the cell membrane, and, if absorbed, readily excreted; iv) geometry of chemicals: planar shape of a molecule has the highest carcinogenic potential; and v) chemical reactivity: chemicals that are highly reactive have lower toxic potential because they hydrolyse or polymerise spontaneously or react with non-critical cellular components before they reach the target (29) . Other factors include the stability of a compound, transport through the membrane, and half-life (2, 57).
Software packages for mutagenicity and carcinogenicity predictions
Due to ethical reasons, reduced resources, and time savings, toxicity testing of chemicals in animals is getting more and more restrictive. This is why chemical and related industries have started to adopt the "3R" (replacement, reduction, and refinement) principle. Two major alternatives to in vivo animal testing are in vitro techniques and in silico computer simulation.
In the last decade, a number of computer programs have been developed to assess the mutagenicity and carcinogenicity based solely on chemical structures as input. Below we present some of the most common software packages for predicting mutagenicity and carcinogenicity of chemical compounds.
VEGA platform and CAESAR
The VEGA platform serves to access a number of QSAR models for predicting mutagenicity and carcinogenicity such as the Computer-Assisted Evaluation of Industrial Chemical Substances According to Regulation (CAESAR). CAESAR is a software tool which was specifically dedicated to develop QSAR mutagenicity models for the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation in collaboration with the United States Environmental Protection Agency (more information is available at: http://www.caesar-project.eu/). Models for predicting mutagenicity are based on a set of 4225 molecules tested with the Ames bacterial test. Models for carcinogenicity were built on a set of 805 chemicals from the Carcinogenic Potency Database (CPDBAS) (58) . CAESAR meets all five principles of the Organisation for Economic Co-operation and Development (OECD). It has good predictive capabilities for mutagenicity and carcinogenicity but, unfortunately, it does not include prediction models for genotoxicity (59) .
DEREK
The Deductive Estimation of Risk from Existing Knowledge (DEREK), developed by LHASA Limited, (Leeds, Great Britain) is a software package that predicts whether a particular substance triggers toxic response based on structural similarity with known toxic compounds and their structural alerts associated with specific endpoints (genotoxicity, mutagenicity, and carcinogenicity). DEREK contains over 75 rules for the Ames mutagenicity endpoint predictions, which are based on empirical relationships and mechanisms of action. The model includes 89 structural alerts for mutagenicity, 77 for chromosome aberrations, and 91 for carcinogenicity. Structural alerts causing genotoxicity are composed of mutagenicity and structural alerts based on data from several in vitro and in vivo mutagenicity tests and other genotoxicity data. The software was developed for research and industry users in collaboration with industry, academia, and regulatory authorities (2, 60) .
TOPKAT
The Toxicity Predictions by Komputer Assisted Technology (TOPKAT) is an expert system developed by Accelrys, Inc. (now Biovia, San Diego, CA, USA). Unlike the two above mentioned software tools, TOPKAT is entirely based on two-dimensional electrotopological descriptors but it also relies on the QSAR model. TOPKAT can predict a wide range of toxicological endpoints, including mutagenicity and carcinogenicity. The results of the program are given numerically (0 -inactive compound; 1 -active compound) based on structural similarity with known toxic and nontoxic compounds. Mutagenicity and carcinogenicity models include data derived from bacterial mutagenicity and rodent carcinogenicity tests. The mutagenicity model is based on data for 393 chemicals from the US EPA GeneTox protocol (60) .
MultiCASE
This expert system is based on the US FDA and EPA for genotoxicity and carcinogenicity endpoints (MultiCASE Inc., Cleveland, OH, USA). It is often used for pharmaceutical toxicity screening of drug candidates with potential for development. It automatically identifies structural alerts with a potential to initiate high biological activity (toxic response) and analyses statistical parameters to get the final predictions. Its mutagenicity and genotoxicity models are based on the Ames mutagenicity, direct mutagenicity, basepair mutagenicity, frameshift mutagenicity, chromosomal aberrations, and sister chromatid exchange data. The carcinogenicity model includes different rodent assays (rate, mouse, male, female, and TD 50 rats) and human epigenetic studies. All models use the statistical approach with the exception of the rule-based model for the Ames mutagenicity. The models are developed according to the OECD rules, the ICH M7 guidelines for impurities in pharmaceuticals, and the REACH guidelines, and therefore targets pharmaceutical and chemical industry in particular (2, 61, 62) .
Another approach for detecting genotoxic compounds that covalently bind to DNA are tools that group similar chemicals into appropriate classes, according to the same structural alerts. Below we present some of the tools that are based on these principles.
QSAR Toolbox
QSAR TOOLBOX is a software application for grouping chemicals into categories and assessing the potential adverse effects of chemicals in cooperation with the European Chemical Agency (ECHA), according to 
Toxtree
Toxtree is a user-friendly, open-source application that predicts various kinds of toxic effects using decision trees to place chemicals into appropriate categories. It estimates mutagenicity and carcinogenicity potentials based on the Benigni-Bossa rules for mutagenicity and carcinogenicity, structural alerts for identification of Michael acceptors, and structural alerts confirmed by positive in vivo micronucleus tests. If a structural alert is present in the molecule, the program recognises the mutagenic and carcinogenic potential of the compound. Input can be entered using the simplified molecular-input line-entry system (SMILES) or 2D structure. The results are colour-coded: green highlight for class I -inactive, yellow highlight for class II -weak activity, and red highlight for class III -active. The program was developed by Ideaconsult Ltd. (Sofia, Bulgaria), for researchers and other stakeholders (especially industry) (1, 61, 64) .
LAZAR
Lazy Structure-Activity Relationships (LAZAR) is an open-source tool for the prediction of complex toxicological endpoints such as carcinogenicity (female/male, hamster/ mouse/rat/rodent) and Salmonella mutagenicity. Unlike other software, LAZAR creates local endpoint QSAR models based on a training set (only nearest neighbours) for each compound separately. It first calculates the molecular descriptors and determines chemical similarity (alerts and compounds) and then it builds a local QSAR model based on a database of experimental toxicity data. Carcinogenicity models are based on CPDB, while the Salmonella mutagenicity model uses a dataset of 3895 compounds determined in vitro. This program meets all five OECD principles (65, 66) .
ACD/Tox Suite
This industry-leading software package was developed to predict various toxicity endpoints such as genotoxicity, carcinogenicity, cytochrome P450 (CYP3A4) inhibition, oestrogen receptor (ER) binding affinity, irritation, rodent acute lethal toxicity (LD 50 ), aquatic toxicity, and organspecific health effects. The predictions are made on the basis of validated QSAR models in combination with expert knowledge of organic chemistry and toxicology. It is primarily intended for ICH M7 submissions in pharmaceutical industry. The software can determine and visualise which parts of molecules, i.e., structural alerts (toxicophores) are responsible for toxic responses and can identify analogues from the training set. The training set is based on compounds that are genotoxic in the Ames test and are taken from the Chemical Carcinogenesis Research Information (CCRIS) and Genetic Toxicology Data Bank (GENE-TOX). Input can be entered as a 2D structure or a SMILES string, and the program yields predictions and up to five similar compounds from the training set (67) .
Leadscope Model Applier
The Model Applier developed by Leadscope, Inc. (Columbus, OH, USA) uses QSAR models for the following endpoints: Salmonella mutagenicity, E. coli mutagenicity, mouse lymphoma, in vitro chromosome aberrations, and in vivo micronuclei. It was developed according to the ICH M7 guideline for impurities and is basically intended for the pharmaceutical industry (68) .
CONCLUSION
In silico methods have become an acceptable alternative to animal testing to fill data gaps and improve the management of chemicals (e.g. the UN Globally Harmonized System of Classification and Labelling of Chemicals, GHS). They are run to submit data for regulatory purposes (e. g. REACH) and to obtain marketing authorisation for pharmaceuticals. In the past decade, several software applications have been designed to use data systems involving molecular descriptors specific to toxic endpoints and reference databases with the aim to predict the properties of new compounds.
All studies so far have shown that mutagenicity and carcinogenicity are parallel, although carcinogenicity is much more complex than mutagenicity. Understanding the mechanisms of covalent binding of chemicals with nucleophilic cellular targets enable us to group chemical compounds with similar mechanisms of action and similar toxic (mutagenic and carcinogenic) effects on the cell (11) . Knowledge of the interconnections between the structure and mechanisms of action of potentially carcinogenic compounds helps us to understand these events.
